-
Navigating Uncertainty Within a Re-evaluation Process: Epidemiological Approach vs Real-World Data in a Budget Impact Analysis for CAR T-cell Therapies in Quebec
Mar 27, 2025, 21:39 PM -
Long Term Healthcare Costs and Utilization Among Patients with Non Obstructive Hypertrophic Cardiomyopathy
Mar 27, 2025, 21:39 PM -
Healthcare Resource Utilization (HCRU) and Cost among Patients with Metastatic Melanoma Receiving Nivolumab + Relatlimab (NIVO+RELA) or Nivolumab + Ipilimumab (NIVO+IPI) in the Optum Database
Mar 27, 2025, 21:39 PM -
Economic Burden of Recurrence among Patients with High-Risk Non-Muscle-Invasive Bladder Cancer who Received Bacillus Calmette-Guérin in the United States: A SEER-Medicare Study
Mar 27, 2025, 21:39 PM -
From Research to Policy: Incorporating Patient Preferences for Colorectal Cancer Treatments Into Health Technology Assessment
Mar 27, 2025, 21:39 PM -
Requirements for Patient-Reported Outcome and Data Analytics in Health Technology Assessment in England, France and Germany, and Opportunities for Methods Harmonization across European Markets
Mar 27, 2025, 21:39 PM -
Inclusion of Health-Related Quality of Life (HRQoL) and Other Patient-Reported Outcomes (PROs) in Reimbursement Reviews From the Canadian Agency for Drugs and Technologies in Health (CADTH)
Mar 27, 2025, 21:39 PM -
A Return On Investment Evaluation Of An Antibiotic Audit And Feedback Program Among Family Physicians
Mar 10, 2025, 14:00 PM -
ASCOT: A Case Study in Generating Timely and Meaningful Canadian Real-World Evidence To Support the Data Infrastructure Necessary for Innovative Patient Access
Mar 10, 2025, 14:00 PM -
Virtual Cancer Screening and Support Program: A Model for Improving Cancer Care Continuity Through Screening, Diagnosis, Treatment, and Survivorship
Mar 10, 2025, 14:00 PM -
What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?
Mar 10, 2025, 14:00 PM -
Economic Impact of Immunobiological Therapies in Disease Affecting Skin from the Perspective of Population Health Management in LMIC/LATAM/Brazil
Mar 10, 2025, 14:00 PM -
Health Utilities Associated With Pneumococcal Diseases in Children and Adults in the United States: A Targeted Literature Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Clinician-Reported Outcomes—A Rare Opportunity for Orphan Labels?
Mar 10, 2025, 14:00 PM -
Comparing Ex-Vivo and In-Vivo Administration in CRISPR-Based Gene Therapies for Beta-Thalassemia: A Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Economic Analysis of an Optical Neonatal Skin Maturity Meter (MOMPN) in Brazilian Newborns
Mar 10, 2025, 14:00 PM -
Economic and Healthcare Burden in Patients with Sjögren's Syndrome: A Systematic Review
Mar 10, 2025, 14:00 PM -
The Institute for Clinical and Economic Review’s Incorrect Use of Incremental Cost-Effectiveness Ratios
Mar 10, 2025, 14:00 PM -
Interventions to Improve Adherence and Persistence to Oral Medication: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Is the Biologics Price Competition and Innovation Act Working as Intended?
Mar 10, 2025, 14:00 PM